1 completed, 1 terminated. 1 Early Phase 1, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Enoxacin: new trials by email Literature Review of Enoxacin trials Research Report on Enoxacin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Enoxacin for Amyotrophic Lateral Sclerosis (ALS) Enoxacin, Placebo - Amyotrophic Lateral Sclerosis | Phase 1 / Phase 2 | Completed | McGill University | 8 | 2021-03-26 | 2024-01-26 |
| Patients Response to Early Switch To Oral:Osteomyelitis Study oral antibiotics, intravenous antibiotics - Osteomyelitis | Early Phase 1 | Terminated | Julio Ramirez | 11 | 2014-03-06 | 2021-04-06 |
Amyotrophic Lateral Sclerosis (1) · Osteomyelitis (1)
Julio Ramirez (1) · McGill University (1)
Canada (1) · United States (1)
Angela Genge, MD, FRCP (1) · David Seligson, MD (1) · Julio Ramirez, MD (1)
PMID 15276398, PMID 15840453, PMID 19588358, PMID 22530208, PMID 4902833, PMID 8948280